These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6434103)

  • 1. Plasma lipids and insulin--gall stone disease: a case control study.
    Thornton JR
    Br Med J (Clin Res Ed); 1984 Sep; 289(6448):832. PubMed ID: 6434103
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma insulin, serum lipids and lipoproteins in gall stone disease in non-insulin dependent diabetic subjects: a case control study.
    Laakso M; Suhonen M; Julkunen R; Pyörälä K
    Gut; 1990 Mar; 31(3):344-7. PubMed ID: 2182400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma lipids and insulin in gall stone disease: a case-control study.
    Scragg RK; Calvert GD; Oliver JR
    Br Med J (Clin Res Ed); 1984 Sep; 289(6444):521-5. PubMed ID: 6432171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin and gall stones: a population case control study in southern Italy.
    Misciagna G; Guerra V; Di Leo A; Correale M; Trevisan M
    Gut; 2000 Jul; 47(1):144-7. PubMed ID: 10861277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid pattern and plasma insulin in diabetics with gall stones.
    Caroli A; Del Favero G; Di Mario F
    Gut; 1991 Mar; 32(3):339-40. PubMed ID: 2013438
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to: Serum paraoxonase and malondialdehyde levels in asymptomatic cholelithiasis.
    Atamer A; Atamer Y; Can AS
    Saudi J Gastroenterol; 2016; 22(1):84-5. PubMed ID: 26831617
    [No Abstract]   [Full Text] [Related]  

  • 7. [The relationship between serum lipids, apolipoproteins level and bile lipids level, chemical type of stone].
    Fu X; Gong K; Shao X
    Zhonghua Yi Xue Za Zhi; 1995 Nov; 75(11):656-9, 708. PubMed ID: 8697083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gall-stone composition and biochemical alterations in the serum of patients with cholelithiasis.
    Maqsood R; Zuberi SJ; Nizami HM; Chaudhry SA
    J Pak Med Assoc; 1976 Aug; 26(8):167-8. PubMed ID: 826669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relation between lipid level and gallstone].
    Fu X
    Zhonghua Yi Xue Za Zhi; 1991 Mar; 71(3):136-9, 10. PubMed ID: 1648424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABO blood group and gall stone disease.
    Juvonen T; Niemelä O
    BMJ; 1992 Jul; 305(6844):26-7. PubMed ID: 1489401
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma lipids and gastro-intestinal hormones in subjects with gallstones.
    Stout RW; Balmer JP; Henry RW; Buchanan KD
    Horm Metab Res; 1978 Jul; 10(4):357. PubMed ID: 680634
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of lovastatin and gemfibrozil in subjects with high ratios of total cholesterol to high-density lipoprotein cholesterol.
    Hung YJ; Pei D; Wu DA; Kuo SW; Fuh MM; Jeng C
    J Formos Med Assoc; 1999 Feb; 98(2):104-10. PubMed ID: 10083765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of dyslipidaemia with cholilithiasis and effect of cholecystectomy on the same.
    Malik AA; Wani ML; Tak SI; Irshad I; Ul-Hassan N
    Int J Surg; 2011; 9(8):641-2. PubMed ID: 21933723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin levels and lipoprotein profiles in patients with cholelithiasis.
    Saraç S; Atamer A; Atamer Y; Can AS; Bilici A; Taçyildiz İ; Koçyiğit Y; Yenice N
    J Int Med Res; 2015 Jun; 43(3):385-92. PubMed ID: 25762517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipemia and lipemic fractions in cholelithiasis and noncalculous gall bladder diseases].
    NICROSINI F; GIORGI G
    Arch Med Interna; 1959; 11():26-34. PubMed ID: 14427026
    [No Abstract]   [Full Text] [Related]  

  • 16. Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil.
    Jonkers IJ; Smelt AH; Ledeboer M; Hollum ME; Biemond I; Kuipers F; Stellaard F; Boverhof R; Meinders AE; Lamers CH; Masclee AA
    Gut; 2003 Jan; 52(1):109-15. PubMed ID: 12477770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.
    Koller T; Kollerova J; Hlavaty T; Huorka M; Payer J
    Scand J Gastroenterol; 2012 Feb; 47(2):197-203. PubMed ID: 22182015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABO blood group and gall stone disease.
    Newton J; Goldacre M
    BMJ; 1992 Jul; 305(6847):254. PubMed ID: 1489428
    [No Abstract]   [Full Text] [Related]  

  • 19. Biliary lipid composition in cholesterol microlithiasis.
    Fracchia M; Pellegrino S; Secreto P; Gallo L; Masoero G; Pera A; Galatola G
    Gut; 2001 May; 48(5):702-6. PubMed ID: 11302972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pregnancy and serum lipids--possible relations to cholelithiasis].
    Sobotka J; Ivanová U; Polónyová A
    Zentralbl Gynakol; 1985; 107(1):22-30. PubMed ID: 3984565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.